Kailera Therapeutics, Inc.
KLRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002096997
No open-market purchases or sales by Kailera Therapeutics, Inc. insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $2.57B in total; Soros Fund Management is the only superinvestor holding it.
Politicians who traded KLRA
No member of Congress has reported a trade in Kailera Therapeutics, Inc. shares or options since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.